Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VIP-236 by Vincerx Pharma for Colorectal Cancer: Likelihood of Approval
VIP-236 is under clinical development by Vincerx Pharma and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
VIP-236 by Vincerx Pharma for Gastric Cancer: Likelihood of Approval
VIP-236 is under clinical development by Vincerx Pharma and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
VIP-236 by Vincerx Pharma for Solid Tumor: Likelihood of Approval
VIP-236 is under clinical development by Vincerx Pharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
VIP-236 by Vincerx Pharma for Non-Small Cell Lung Cancer: Likelihood of Approval
VIP-236 is under clinical development by Vincerx Pharma and currently in Phase I for Non-Small Cell Lung Cancer. According to...
VIP-236 by Vincerx Pharma for Adenoid Cystic Carcinoma (ACC): Likelihood of Approval
VIP-236 is under clinical development by Vincerx Pharma and currently in Phase I for Adenoid Cystic Carcinoma (ACC). According to...
VIP-236 by Vincerx Pharma for Endometrial Cancer: Likelihood of Approval
VIP-236 is under clinical development by Vincerx Pharma and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase...